188 related articles for article (PubMed ID: 30817018)
1. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking.
Bold KW; Zweben A; Fucito LM; Piepmeier ME; Muvvala S; Wu R; Gueorguieva R; O'Malley SS
Alcohol Clin Exp Res; 2019 May; 43(5):937-944. PubMed ID: 30817018
[TBL] [Abstract][Full Text] [Related]
2. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
[TBL] [Abstract][Full Text] [Related]
3. Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial.
Dogar O; Zahid R; Mansoor S; Kanaan M; Ahluwalia JS; Jawad M; Siddiqi K
Addiction; 2018 Dec; 113(12):2290-2299. PubMed ID: 30187978
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
[TBL] [Abstract][Full Text] [Related]
5. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Lim AC; Roche DJO; Ray LA
J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
[TBL] [Abstract][Full Text] [Related]
6. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
7. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
[TBL] [Abstract][Full Text] [Related]
8. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials.
Haeny AM; Gueorguieva R; Montgomery L; Bold KW; Fucito LM; Wu R; Muvvala SB; Zweben A; O'Malley SS
Addict Behav; 2021 Nov; 122():106970. PubMed ID: 34216871
[TBL] [Abstract][Full Text] [Related]
9. Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
Versace F; Stevens EM; Robinson JD; Cui Y; Deweese MM; Engelmann JM; Green CE; Karam-Hage M; Lam CY; Minnix JA; Wetter DW; Cinciripini PM
Nicotine Tob Res; 2019 Jan; 21(2):234-240. PubMed ID: 29220524
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
[TBL] [Abstract][Full Text] [Related]
11. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults.
McClure EA; Baker NL; Hood CO; Tomko RL; Squeglia LM; Flanagan JC; Carpenter MJ; Gray KM
Nicotine Tob Res; 2020 Jul; 22(8):1374-1382. PubMed ID: 31612956
[TBL] [Abstract][Full Text] [Related]
12. Alcohol use disorder severity moderates clinical response to varenicline.
Donato S; Green R; Ray LA
Alcohol Clin Exp Res; 2021 Sep; 45(9):1877-1887. PubMed ID: 34486130
[TBL] [Abstract][Full Text] [Related]
13. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Varenicline for Smoking Cessation in Alcohol-Dependent Smokers in Concurrent Treatment for Alcohol Use Disorder: A Pilot, Randomized Placebo-Controlled Trial.
Zawertailo L; Ivanova A; Ng G; Le Foll B; Selby P
J Clin Psychopharmacol; 2020; 40(2):130-136. PubMed ID: 32068562
[TBL] [Abstract][Full Text] [Related]
15. The effect of varenicline on mood and cognition in smokers with HIV.
Thompson M; Schnoll R; Serrano K; Leone F; Gross R; Collman RG; Ashare RL
Psychopharmacology (Berl); 2020 Apr; 237(4):1223-1231. PubMed ID: 31938877
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
Schnoll R; Leone F; Veluz-Wilkins A; Miele A; Hole A; Jao NC; Paul Wileyto E; Carroll AJ; Kalhan R; Patel J; Langer C; Lubitz SF; Hitsman B
Psychooncology; 2019 Mar; 28(3):561-569. PubMed ID: 30680852
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal associations between smoking and affect among cancer patients using varenicline to quit smoking.
Carroll AJ; Kim K; Miele A; Olonoff M; Leone FT; Schnoll RA; Hitsman B
Addict Behav; 2019 Aug; 95():206-210. PubMed ID: 30978583
[TBL] [Abstract][Full Text] [Related]
18. Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial.
Le Mao R; Tromeur C; Paleiron N; Sanchez O; Gagnadoux F; Jouneau S; Magnan A; Hayem-Vannimenus C; Dansou A; Proust A; Dion A; Larhantec G; Brestec AL; Dewitte JD; Roche N; Leroyer C; Couturaud F
COPD; 2020 Feb; 17(1):7-14. PubMed ID: 31854207
[TBL] [Abstract][Full Text] [Related]
19. A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
Russo C; Caponnetto P; Cibella F; Maglia M; Alamo A; Campagna D; Frittitta L; Di Mauro M; Leotta C; Mondati E; Krysiński A; Franek E; Polosa R
Intern Emerg Med; 2021 Oct; 16(7):1823-1839. PubMed ID: 33735416
[TBL] [Abstract][Full Text] [Related]
20. Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo.
Littlewood RA; Claus ED; Wilcox CE; Mickey J; Arenella PB; Bryan AD; Hutchison KE
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3417-3429. PubMed ID: 28889258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
